Literature DB >> 2565494

Rising mortality from motoneuron disease.

T P Flaten.   

Abstract

Mesh:

Year:  1989        PMID: 2565494     DOI: 10.1016/s0140-6736(89)92661-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Motor neuron disease and polio in Scotland.

Authors:  R J Swingler; H Fraser; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

2.  Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

Authors:  A M Chancellor; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

Review 3.  Poliovirus and motor neuron disease.

Authors:  C N Martyn
Journal:  J Neurol       Date:  1990-10       Impact factor: 4.849

4.  Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease.

Authors:  A M Chancellor; R J Swingler; H Fraser; J A Clarke; C P Warlow
Journal:  J Epidemiol Community Health       Date:  1993-04       Impact factor: 3.710

5.  The environment in childhood and risk of motor neuron disease.

Authors:  C N Martyn; C Osmond
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

6.  Motor neuron disease in a defined English population: estimates of incidence and mortality.

Authors:  G Dean; M Quigley; M Goldacre
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

7.  Rising amyotrophic lateral sclerosis mortality in France 1968-1990: increased life expectancy and inter-disease competition as an explanation.

Authors:  S Neilson; I Robinson; A Alperovitch
Journal:  J Neurol       Date:  1994-06       Impact factor: 4.849

8.  Motor neuron disease and multiple sclerosis mortality in Australia, New Zealand and South Africa compared with England and Wales.

Authors:  G Dean; M Elian
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.